A Novel Strategy for the Enhancement of Drug Absorption Using a Claudin Modulator

Authors:
  • AMAkane Masuyama
    Akane Masuyama
  • ATAzusa Takahashi
    Azusa Takahashi
  • NANagayoshi Asano
    Nagayoshi Asano
  • HMHiroyuki Mizuguchi
    Hiroyuki Mizuguchi
  • NKNaoya Koizumi
    Naoya Koizumi
  • MFMakiko Fujii
    Makiko Fujii
  • THTakao Hayakawa
    Takao Hayakawa
  • YHYasuhiko Horiguchi
    Yasuhiko Horiguchi
  • YWYoshiteru Watanbe
    Yoshiteru Watanbe

Abstract
Claudin, a tight junction integral membrane protein and a family of proteins, forms the actual sealing element of the tight junction. There are more than 20 members of the claudin family with different tissue-specific expression and barrier functions. Thus, a family of claudin may be a target for modifying the absorption of drugs. Here, we examined whether modulation of claudin could be used to enhance drug absorption. In the current studies, we used a C-terminal fragment of Clostridium perfringens enterotoxin (C-CPE) as a modulator of claudin-4. The absorption of dextran was assessed in an in situ loop assay in rats to evaluate the absorption-enhancing effects of C-CPE. Treatment with C-CPE dose-dependently enhanced the absorption of dextran (mol. wt. 4000). These effects were not accompanied by injury of the intestinal mucosa as assessed by leakage of lactose dehydrogenase and histological observation. C-CPE was over 400-fold more potent at enhancing dextran absorption than capric acid, a clinically used enhancer of absorption. C-CPE interacted directly with claudin-4, and C-CPE lacking a part the C terminus neither bound claudin-4 nor enhanced absorption in the rat jejunum. These results suggest that C-CPE enhances the absorption of dextran in rat jejunum, apparently through interactions with claudin-4, and this effect may represent an effective novel strategy for enhancing the absorption of drugs.

This publication has 35 references indexed in Scilit: